Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Pulmonology Reports
Published in: Current Pulmonology Reports 4/2019

01-12-2019 | Hypersensitivity Pneumonitis | Interstitial Lung Disease (A Hajari Case, Section Editor)

Hypersensitivity Pneumonitis (Including Environmental Assessment): Diagnosis and Management

Authors: Wing Sun Tam, Tasnim Islam, Anoop M. Nambiar

Published in: Current Pulmonology Reports | Issue 4/2019

Login to get access

Abstract

Purpose of Review

This article aims to provide an overview on the diagnosis and management of hypersensitivity pneumonitis (HP). We will focus on the issues surrounding the lack of an international consensus on the diagnosis of HP, and review the existing treatment options for HP.

Recent Findings

There is emerging international consensus that HP should be classified based on clinical, radiologic, and pathologic features and not solely on disease duration. Environmental assessment and antigen avoidance remains the most important step in managing HP. Antifibrotics may soon become a viable option for chronic HP in the near future. Well-designed prospective controlled studies are underway.

Summary

Substantial gaps still remain in our understanding of the diagnosis and management of HP. Further research should focus on establishing internationally accepted diagnostic criteria and clinical practice guidelines to aid the clinician in the challenging treatment of patients with HP.
Literature
1.
•• Vasakova M, Selman M, Morell F, Sterclova M, Molina-Molina M, Raghu G. Hypersensitivity pneumonitis: current concepts of pathogenesis and potential targets for treatment. Am J Respir Crit Care Medicine. 2019;200:301–8. Important review on our current understanding of HP pathogenesis and potential therapeutic targets for the treatment of HP.
2.
Pérez ER, Swigris JJ, Forssén AV, Tourin O, Solomon JJ, Huie TJ, et al. Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest. 2013;144(5):1644–51.
3.
Lacasse Y, Selman M, Costabel U, Dalphin JC, Morell F, Erkinjuntti-Pekkanen R, et al. Classification of hypersensitivity pneumonitis. International archives of allergy and immunology. 2009;149(2):161–6.PubMed
4.
Zacharisen MC, Schlueter DP, Kurup VP, Fink JN. The long-term outcome in acute, subacute, and chronic forms of pigeon breeder’s disease hypersensitivity pneumonitis. Annals of Allergy, Asthma & Immunology. 2002;88(2):175–82.
5.
Ohtani Y, Saiki S, Sumi Y, Inase N, Miyake S, Costabel U, et al. Clinical features of recurrent and insidious chronic bird fancier's lung. Annals of Allergy, Asthma & Immunology. 2003;90(6):604–10.
6.
Tateishi T, Ohtani Y, Takemura T, Akashi T, Miyazaki Y, Inase N, et al. Serial high-resolution computed tomography findings of acute and chronic hypersensitivity pneumonitis induced by avian antigen. Journal of computer assisted tomography. 2011;35(2):272–9.PubMed
7.
•• Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity pneumonitis: perspectives in diagnosis and management. American journal of respiratory and critical care medicine. 2017;196(6):680–9. Key review on HP that proposed classification schema for HP as “acute/inflammatory” vs. “chronic/fibrotic”. PubMed
8.
•• Salisbury ML, Myers JL, Belloli EA, Kazerooni EA, Martinez FJ, Flaherty KR. Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go. American journal of respiratory and critical care medicine. 2017;196(6):690–9. Key review on HP. Recommends treating HP according to whether inflammatory features are present or not. PubMedPubMedCentral
9.
Pérez-Padilla R, Salas J, Chapela R, Sánchez M, Carrillo G, Pérez R, et al. Mortality in Mexican patients with chronic pigeon breeder’s lung compared with those with usual interstitial pneumonia. American Review of Respiratory Disease. 1993;148:49.PubMed
10.
Ohtani Y, Saiki S, Kitaichi M, Usui Y, Inase N, Costabel U, et al. Chronic bird fancier’s lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax. 2005;60(8):665–71.PubMedPubMedCentral
11.
Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. The American journal of surgical pathology. 2006;30(2):201–8.PubMed
12.
Chiba S, Tsuchiya K, Akashi T, Ishizuka M, Okamoto T, Furusawa H, et al. Chronic hypersensitivity pneumonitis with a usual interstitial pneumonia-like pattern: correlation between histopathologic and clinical findings. Chest. 2016;149(6):1473–81.PubMed
13.
Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, et al. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. The American journal of medicine. 2004;116(10):662–8.PubMed
14.
Pérez F, Evans R, et al. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Annals of the American Thoracic Society. 2018;15.4:460–9.
15.
16.
Nogueira R, Melo N, e Bastos HN, Martins N, Delgado L, Morais A, et al. Hypersensitivity pneumonitis: antigen diversity and disease implications. Pulmonology. 2019;25(2):97–108.PubMed
17.
18.
Bourke SJ, Dalphin JC, Boyd G, McSharry C, Baldwin CI, Calvert JE. Hypersensitivity pneumonitis: current concepts. European Respiratory Journal. 2001;18(32 suppl):81s–92s.
19.
Reich JM. Chirping rales in bird-fancier’s lung. Chest. 1993;104(1):326–7.PubMed
20.
Fenoglio CM, Reboux G, Sudre B, Mercier M, Roussel S, Cordier JF, et al. Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. European Respiratory Journal. 2007;29(4):706–12.PubMed
21.
Van Hoeyveld E, Dupont L, Bossuyt X. Quantification of IgG antibodies to Aspergillus fumigatus and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique? Clinical chemistry. 2006;52(9):1785–93.PubMed
22.
Raulf M, Joest M, Sander I, Hoffmeyer F, Nowak D, Ochmann U, Preisser A, Schreiber J, Sennekamp J, Koschel D. Update of reference values for IgG antibodies against typical antigens of hypersensitivity pneumonitis. Allergo J Int. 2019;1–2.
23.
Lynch DA, Newell JD, Logan PM, King TE Jr, Müller NL. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?. AJR. American journal of roentgenology. 1995;165(4):807–11.PubMed
24.
Silva CI, Muller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008;246(1):288–97.PubMed
25.
Hansell DM, Wells AU, Padley SP, Müller NL. Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities. Radiology. 1996;199(1):123–8.PubMed
26.
Lynch DA, Rose CS. Way D, King Jr TE. Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR. American journal of roentgenology. 1992;159(3):469–72.PubMed
27.
Silva CI, Churg A, Müller NL. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. American Journal of Roentgenology. 2007;188(2):334–44.PubMed
28.
Sahin H, Brown KK, Curran-Everett D, Hale V, Cool CD, Vourlekis JS, et al. Chronic hypersensitivity pneumonitis: CT features—comparison with pathologic evidence of fibrosis and survival. Radiology. 2007;244(2):591–8.PubMed
29.
Chung JH, Zhan X, Cao M, Koelsch TL, Manjarres DC, Brown KK, et al. Presence of air trapping and mosaic attenuation on chest computed tomography predicts survival in chronic hypersensitivity pneumonitis. Annals of the American Thoracic Society. 2017;14(10):1533–8.PubMed
30.
• Barnett J, Molyneaux PL, Rawal B, Abdullah R, Hare SS, Vancheeswaran R, et al. Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. European Respiratory Journal. 2019;54(1):1900531. Interesting study that noted the presence of mosaic attenuation in 51% of IPF patients and found the “headcheese sign” to be a highly specific radiologic finding for fibrotic HP. PubMed
31.
Aburto M, Herráez I, Iturbe D, Jiménez-Romero A. Diagnosis of idiopathic pulmonary fibrosis: differential diagnosis. Medical Sciences. 2018;6(3):73.PubMedCentral
32.
Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine. 2009;179(11):1043–7.PubMed
33.
• Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SL, et al. Identification of diagnostic criteria for chronic hypersensitivity pneumonitis. An International Modified Delphi Survey. American journal of respiratory and critical care medicine. 2018;197(8):1036–44. Recent Delphi survey among international HP experts on consensus diagnostic features of chronic HP. PubMedPubMedCentral
34.
Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. American journal of respiratory and critical care medicine. 2012;185(9):1004–14.PubMed
35.
• Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. American journal of respiratory and critical care medicine. 2018;198(5):e44–68. Most recent IPF clinical practice guidelines for the diagnosis of IPF. PubMed
36.
Adams TN, Newton CA, Batra K, Abu-Hijleh M, Barbera T, Torrealba J, et al. Utility of bronchoalveolar lavage and transbronchial biopsy in patients with hypersensitivity pneumonitis. Lung. 2018;196(5):617–22.PubMedPubMedCentral
37.
Trahan S, Hanak V, Ryu JH, Myers JL. Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis*: analysis of 31 biopsies from 15 patients. Chest. 2008;134(1):126–32.PubMed
38.
Sharp C, McCabe M, Adamali H, Medford AR. Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease—a systematic review and cost analysis. QJM: An International Journal of Medicine. 2016;110(4):207–14.
39.
Takemura T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med. 2008;14(5):440–54.PubMed
40.
Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009;33:1765–70.PubMed
41.
Ohtani Y, Kojima K, Sumi Y, Sawada M, Inase N, Miyake S, et al. Inhalation provocation tests in chronic bird fancier’s lung. Chest. 2000;118:1382–9.PubMed
42.
Walsh SL, Sverzellati N, Devaraj A, Wells AU, Hansell DM. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. European radiology. 2012;22(8):1672–9.PubMed
43.
Morell F, Villar A, Montero MÁ, Muñoz X, Colby TV, Pipvath S, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. The lancet Respiratory medicine. 2013;1(9):685–94.PubMed
44.
• Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SL, Myers JL, et al. A standardized diagnostic ontology for fibrotic interstitial lung disease. An international working group perspective. American journal of respiratory and critical care medicine. 2017;196(10):1249–54. Provides a framework for the standardization of diagnostic confidence in ILD. PubMedPubMedCentral
45.
Elicker BM, Jones KD, Henry TS, Collard HR. Multidisciplinary approach to hypersensitivity pneumonitis. Journal of thoracic imaging. 2016;31(2):92–103.PubMed
46.
Sema M, Miyazaki Y, Tsutsui T, Tomita M, Eishi Y, Inase N. Environmental levels of avian antigen are relevant to the progression of chronic hypersensitivity pneumonitis during antigen avoidance. Immunity, inflammation and disease. 2018;6(1):154–62.PubMed
47.
De Gracia J, Morell F, Bofill JM, Curull V, Orriols R. Time of exposure as a prognostic factor in avian hypersensitivity pneumonitis. Respiratory medicine. 1989;83(2):139–43.PubMed
48.
Quirce S, Vandenplas O, Campo P, Cruz MJ, de Blay F, Koschel D, et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016;71(6):765–79.
49.
Millerick-May ML, Mulks MH, Gerlach J, Flaherty KR, Schmidt SL, Martinez FJ, et al. Hypersensitivity pneumonitis and antigen identification–an alternate approach. Respiratory medicine. 2016;112:97–105.PubMed
50.
Craig TJ, Hershey J, Engler RJ, Davis W, Carpenter GB, Salata K. Bird antigen persistence in the home environment after removal of the bird. Annals of allergy. 1992;69(6):510–2.PubMed
51.
Ohshimo S, Bonella F, Guzman J, Costabel U. Hypersensitivity pneumonitis. Immunology and Allergy Clinics. 2012;32(4):537–56.
52.
Kokkarinen JI, Tukiainen HO, Terho EO. Effect of corticosteroid treatment on the recovery of pulmonary function in farmer’s lung 1-3. Am Rev Respir Dis. 1992;145:3–5.PubMed
53.
Mönkäre S. Influence of corticosteroid treatment on the course of farmer’s lung. European journal of respiratory diseases. 1983;64(4):283–93.PubMed
54.
De Sadeleer L, Hermans F, De Dycker E, Yserbyt J, Verschakelen J, Verbeken E, et al. Effects of corticosteroid treatment and antigen avoidance in a large hypersensitivity pneumonitis cohort: a single-centre cohort study. Journal of clinical medicine. 2019;8(1):14.
55.
Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, et al. Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis. Chest. 2017;151(3):619–25.PubMed
56.
Adegunsoye A, Oldham JM, Pérez ER, Hamblin M, Patel N, Tener M, et al. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis. ERJ open research. 2017;3(3):00016–2017.PubMedPubMedCentral
57.
Keir GJ, Maher TM, Ming D, Abdullah R, de Lauretis A, Wickremasinghe M, et al. Rituximab in severe, treatment-refractory interstitial lung disease. Respirology. 2014 Apr;19(3):353–9.PubMed
58.
Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27:180076.PubMed
59.
Shibata S, Furusawa H, Inase N. Pirfenidone in chronic hypersensitivity pneumonitis: a real-life experience. Sarcoidosis vasculitis and diffuse lung disease. 2018;35(2):139–42.
60.
Behr J, Neuser P, Prasse A, Kreuter M, Rabe K, Schade-Brittinger C, et al. Exploring efficacy and safety of oral pirfenidone for progressive, non-IPF lung fibrosis (RELIEF): a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial. BMC Pulm Med. 2017;17:122.PubMedPubMedCentral
61.
Flaherty KR, Brown KK, Wells AU, Clerisme-Beaty E, Collard HR, Cottin V, et al. Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ open respiratory research. 2017;4(1):e000212.PubMedPubMedCentral
62.
Kern RM, Singer JP, Koth L, Mooney J, Golden J, Hays S, et al. Lung transplantation for hypersensitivity pneumonitis. Chest. 2015;147(6):1558–65.PubMed
63.
Sansores R, Salas J, Chapela R, Barquin N, Selman M. Clubbing in hypersensitivity pneumonitis: its prevalence and possible prognostic role. Archives of internal medicine. 1990;150(9):1849–51.PubMed
64.
Gimenez A, Storrer K, Kuranishi L, Soares MR, Ferreira RG, Pereira CA. Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis. Thorax. 2018;73(4):391–2.PubMed
65.
Miyazaki Y, Tateishi T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest. 2008;134(6):1265–70.PubMed
66.
Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014;145(4):723–8.PubMed
67.
Mooney JJ, Elicker BM, Urbania TH, Agarwal MR, Ryerson CJ, Nguyen ML, et al. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest. 2013;144(2):586–92.PubMed
68.
Hanak V, Golbin JM, Hartman TE, Ryu JH. High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. Chest. 2008;134(1):133–8.PubMed
69.
• Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M, et al. Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory. Chest. 2019;155(4):699–711. Recent paper on classifying HRCT findings of HP patients into three phenotypes. PubMed
70.
Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, et al. Pathologic findings and prognosis in a large prospective cohort of chronic hypersensitivity pneumonitis. Chest. 2017;152(3):502–9.PubMed
71.
Nukui Y, Miyazaki Y, Masuo M, Okamoto T, Furusawa H, Tateishi T, Kishino M, Tateishi U, Ono J, Ohta S, Izuhara K. Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis. Allergology International. 2019.
Metadata
Title
Hypersensitivity Pneumonitis (Including Environmental Assessment): Diagnosis and Management
Authors
Wing Sun Tam
Tasnim Islam
Anoop M. Nambiar
Publication date
01-12-2019
Publisher
Springer US
Published in
Current Pulmonology Reports / Issue 4/2019
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-019-00239-6

Other articles of this Issue 4/2019

Current Pulmonology Reports 4/2019 Go to the issue

Interventional Pulmonology (G Cheng, Section Editor)

Update on Management of Pleural Disease

Interventional Pulmonology (G Cheng, Section Editor)

Bronchoscopic Lung Volume Reduction Using Endobronchial Valves: How to Do It

Interventional Pulmonology (G Cheng, Section Editor)

Bronchoscopy: Past, Present, and Future

Bronchiectasis (A Schmid, Section Editor)

Duration of Antibiotic Therapy in Non-cystic Fibrosis Bronchiectasis

Interventional Pulmonology (G Cheng, Section Editor)

Hemoptysis: Rethinking Management

Bronchiectasis (A Schmid, Section Editor)

Nontuberculous Mycobacteria Infection: Source and Treatment
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits